Earnings & Reporting

Stephen Curley takes the helm at Eagle Bancorp, signaling a strategic pivot to tackle real estate loan challenges and drive diversified growth.

Vishay Precision Group beats Q1 estimates, driving a stock surge. Record bookings and a foray into the booming humanoid robotics market signal a new era of growth.

Despite a narrow EPS miss, Sea's stock surged on stellar Q1 revenue. A deep dive into Shopee, Monee, and Garena's performance and its AI ambitions.

Despite a net loss, Ampco-Pittsburgh posts record results in one segment and a growing backlog, signaling a potential turnaround for the rest of 2026.

Despite mixed GAAP figures, Novanta's huge jump in orders and strong cash flow point to a robust outlook driven by tech's hottest sectors.

The AIoT giant reports strong Q1 profits, proving its AI-first strategy is paying off amidst global headwinds and a rapidly growing developer ecosystem.

A massive acquisition and a surge in urea prices propelled Adecoagro to a record quarter, offsetting commodity slumps and redefining its future.

The Canadian digital media firm moves to repurchase shares and bolster its pension plan, signaling a mature strategy focused on shareholder value and stability.

Anaveon reveals promising ASCO data for its cancer drug ANV600, yet puts the asset on the market to fund a bold new focus on autoimmune diseases.

Formula 1 meets pet couture as VETRESKA partners with Ollie Bearman, signaling a new era of lifestyle brand sponsorships in high-speed motorsport.

As a 30-year veteran retires, TransAct Technologies appoints a new CFO to accelerate its critical shift towards a cloud-based, recurring revenue model.

Copper Property Trust's upcoming call will offer a rare look into the liquidation of J.C. Penney's old stores and the future of big-box retail real estate.

The legal finance giant appoints Travis Lenkner as COO and promotes Carrie Tendler, signaling a renewed focus on operational execution and asset recovery.

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

Despite strong earnings, LifeStance shares fall after a major investor sale. The company's own share repurchase signals a complex financial strategy.

Amid declining Q1 income and NAV, the lender bets on a major healthcare acquisition and a new buyback to bolster shareholder confidence and future growth.

Despite a Q1 net loss, Mach Natural Resources boosts its cash distribution and shifts capital to oil, signaling confidence in its operational strength.

The cloud company's results show modest growth, but a strategic pivot to shed a recent acquisition and focus on its 'Dash' AI tool is paying off.

Rogers Corporation adds two powerhouse CEOs to its board, signaling a strategic push to dominate high-growth markets like EVs and advanced industrial tech.

With a new CEO focused on digital sales and subscriptions, SenesTech aims to capture the growing market for eco-friendly pest management solutions.